Zhixiang M. Zhuang
Suzhou, 215004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Neuroprotection and prevention of oxaliplatin-induced neuropathy with Huangqi Guizhi Wuwu Decoction: a 12-center randomized, double-blind trial with mechanistic validation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 04, 2026
Circ_PRKCA drove NSCLC progression via SRSF1/HIF-1A/PKM2 axis-mediated glycolytic reprogramming.
Journal: Experimental cell research
Published: October 16, 2025
Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study.
Journal: Signal transduction and targeted therapy
Published: August 25, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: March 27, 2025
Development and Characterization of the [177Lu]Lu-Labeled Anti-CDH17 Nanobody Derivative for Radioimmunotherapy in the Gastric Cancer Xenograft Model.
Journal: Molecular pharmaceutics
Published: March 15, 2025
Predicting extensive metastasis in postoperative oligometastatic colorectal cancer.
Journal: International journal of colorectal disease
Published: February 16, 2025
Leucine rich repeat containing 15 promotes triple-negative breast cancer proliferation and invasion via the ITGB1/FAK/PI3K signalling pathway.
Journal: Scientific reports
Published: November 14, 2024
Igniting tumour microenvironment in triple-negative breast cancer using a mannose/hyaluronic acid dual-coated Ganoderma polysaccharide-superparamagnetic iron oxide nanocomplex for combinational therapies.
Journal: Journal of drug targeting
Published: October 29, 2024
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: September 29, 2024
Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial.
Journal: Cancer communications (London, England)
Published: June 07, 2024
Causal Relationships of Chronic Constipation and Irritable Bowel Syndrome with Digestive Tract Cancers: A Mendelian Randomization Study.
Journal: Recent patents on anti-cancer drug discovery
Published: September 20, 2023
Last Updated: 09/26/2026